2013 February
Biosortia Pharmaceuticals Creating Drug Discovery Opportunity with Previously Unstudied Microorganisms. Dublin, Ohio (February 26, 2013) – The Ohio State University has signed an agreement with Biosortia Pharmaceuticals of Dublin, Ohio to discover new biologically active natural products with potential anti-cancer activity. Potential candidate compounds discovered during the Biosortia-sponsored research project will primarily be tested against human
Continue ReadingDublin, Ohio (February 25, 2013) – On March 6th the Columbus Metropolitan Club at the Athletic Club of Columbus will host a lunch meeting where Biosortia Pharmaceuticals’ President & CEO Kurt Dieck along with founder Ross Youngs will share a look at the vast potential for a whole new world of biopharmaceutical drug discovery from aquatic
Continue ReadingRoss Youngs Founder of Biosortia Pharmaceuticals accepted a Proclamation as an Entrepreneurial representative that recognizes how vital entrepreneurship is to growth and prosperity from Timothy A. Lecklider, Mayor of Dublin Ohio. Recognition to Tech Columbus, the Dublin Entrepreneurial Center, and National Entrepreneurship Week was highlighted during the presentation. COMMENTS BY ROSS YOUNGS FOUNDER BIOSORTIA PHARMACEUTICALS
Continue ReadingBy Carrie Ghose, (February 1, 2013) – The same mystery toxins from blooms of algae that sicken swimmers and kill fish also might be the source of drugs to fight cancer or drug-resistant bacteria. Biosortia Pharmaceuticals, a subsidiary of Marysville-based Algaeventure Systems Inc., is prospecting wild waterways for rare and previously unidentified chemicals that could be
Continue Reading